NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first quarter 2014 revenues grew 6 percent, driven by an 18 percent spike in assay sales, as well as an increase in consumables sales.

Austin, Texas-based Luminex reported total revenues of $56.6 million for the three months ended March 31, compared to revenues of $53.2 million for the first quarter of 2013. It beat the consensus Wall Street estimate for revenues of $55.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.